Lonza Group AG Lonza Group AG

Lonza Group AG

LONN

株式のランク #447
Lonza Group AG, together with its subsidiaries, operates as a contract... Lonza Group AG, together with its subsidiaries, operates as a contract development and manufacturing organization for pharma and biotech companies in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally. It operates through Integrated Biologics; Advanced Synthesis; and Specialized Modalities segments. The Integrated Biologics segment offers CDMO biologics services from clinical development, drug substance, and drug product manufacturing; and operates mammalian and drug product platforms. Its Advanced Synthesis segment manufactures antibody-drug conjugates (ADCs) and other bioconjugates, small molecules, and highly potent active pharmaceutical ingredients; and operates small molecules and bioconjugates platforms. The Specialized Modalities segment operates various technologies, such as spanning cell & gene, microbial, bioscience, and mRNA. Lonza Group AG was incorporated in 1897 and is headquartered in Basel, Switzerland.
株価
$766.95
時価総額
$53.57B
変化(1日)
1.35%
変化(1年)
9.01%
国
CH
取引 Lonza Group AG (LONN)

カテゴリー

Healthcare
Lonza Group AG(LONN)のP/B比率
2026 時点のP/B比率 TTM: 0
Lonza Group AG の最新の財務報告および株価によると、現在のP/B比率(TTM)は 0 です。2026 年末時点でのP/B比率は 0 でした。
Lonza Group AG の P/B 比率の履歴(2004 ~ 2026)
各年末時点のP/B比率
年 P/B比率 変化
2025 4.12 0.78%
2024 4.09 48.44%
2023 2.76 -13.17%
2022 3.17 -45.28%
2021 5.80 -6.60%
2020 6.21 54.07%
2019 4.03 31.99%
2018 3.05 4.80%
2017 2.91 -20.51%
2016 3.67 -1.63%
2015 3.73 46.34%
2014 2.55 32.62%
2013 1.92 76.08%
2012 1.09 -10.31%
2011 1.22 -26.13%
2010 1.65 3.24%
2009 1.59 -44.54%
2008 2.87 -28.32%
2007 4.01 12.01%
2006 3.58 40.08%
2005 2.56 8.33%
2004 2.36 0.00%
同業他社のP/B比率
企業 P/B比率 P/B比率の差 国
6.251 -
US
13.2547 -
US
4.4521 -
AU
6.3632 -
NL
3.2932 -
BE